Related Experiment Video
Updated: Jul 10, 2026
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
Immunotherapy with dendritic cells for cancer
Alberto Ballestrero1, Davide Boy, Eva Moran
1Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy.
Advanced Drug Delivery Reviews
|November 6, 2007
Summary
Dendritic cell vaccines harness antigen-presenting cells to stimulate immunity. Research explores in vivo antigen targeting and dendritic cell (DC) immunogenicity for improved cancer immunotherapy and patient survival.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Dendritic cells (DCs) are crucial antigen-presenting cells (APCs) essential for initiating immune responses and maintaining tolerance.
- DCs possess specialized functions in antigen capture, processing, and presentation, alongside co-stimulatory signals that activate T lymphocytes and NK cells.
Purpose of the Study:
- To review recent advancements in dendritic cell vaccine technology.
- To discuss novel strategies for targeting antigens to DCs in vivo.
- To provide an overview of current and future clinical applications of DC-based immunotherapy.
Main Methods:
- Review of existing literature on dendritic cell biology and immunotherapy.
- Analysis of clinical studies involving dendritic cell vaccines.
- Discussion of emerging mechanisms controlling DC immunogenicity and immune orchestration.
Main Results:
- Ex vivo generated and antigen-loaded DCs effectively induce antigen-specific immunity.
- In vivo antigen targeting methods are emerging, reducing the need for ex vivo cell manipulation.
- Ongoing studies are evaluating DC vaccines for preventing tumor relapse and improving patient survival.
Conclusions:
- Understanding DC immunogenicity and immune orchestration mechanisms is key to advancing DC-based immunotherapy.
- Dendritic cell vaccines hold significant promise for cancer treatment and are expected to see wider implementation.
- Further research into DC dynamics and clinical efficacy will drive the future of this immunotherapy approach.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...